These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12878511)

  • 1. Selection of resistant Streptococcus pneumoniae during penicillin treatment in vitro and in three animal models.
    Knudsen JD; Odenholt I; Erlendsdottir H; Gottfredsson M; Cars O; Frimodt-Møller N; Espersen F; Kristinsson KG; Gudmundsson S
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2499-506. PubMed ID: 12878511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillin pharmacodynamics in four experimental pneumococcal infection models.
    Erlendsdottir H; Knudsen JD; Odenholt I; Cars O; Espersen F; Frimodt-Møller N; Fuursted K; Kristinsson KG; Gudmundsson S
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1078-85. PubMed ID: 11257018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of pharmacodynamic properties in treatment of penicillin resistant Streptococcus pneumoniae.
    Knudsen JD
    Dan Med Bull; 2000 Nov; 47(5):313-27. PubMed ID: 11155659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
    Moine P; Vallée E; Azoulay-Dupuis E; Bourget P; Bédos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):1953-8. PubMed ID: 7811003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against pneumococci with various susceptibilities to penicillin.
    Knudsen JD; Frimodt-Møller N; Espersen F
    Antimicrob Agents Chemother; 1995 Jun; 39(6):1253-8. PubMed ID: 7574511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of penicillin resistance on outcome in adult patients with invasive pneumococcal pneumonia: is penicillin useful against intermediately resistant strains?
    Falcó V; Almirante B; Jordano Q; Calonge L; del Valle O; Pigrau C; Planes AM; Gavaldà J; Pahissa A
    J Antimicrob Chemother; 2004 Aug; 54(2):481-8. PubMed ID: 15215226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacies of cefotaxime and ceftriaxone in a mouse model of pneumonia induced by two penicillin- and cephalosporin-resistant strains of Streptococcus pneumoniae.
    Sauve C; Azoulay-Dupuis E; Moine P; Darras-Joly C; Rieux V; Carbon C; Bédos JP
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2829-34. PubMed ID: 9124850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia.
    Azoulay-Dupuis E; Vallee E; Veber B; Bedos JP; Bauchet J; Pocidalo JJ
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2698-703. PubMed ID: 1336343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model.
    Tateda K; Takashima K; Miyazaki H; Matsumoto T; Hatori T; Yamaguchi K
    Antimicrob Agents Chemother; 1996 Jun; 40(6):1520-5. PubMed ID: 8726030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How can we predict bacterial eradication?
    Jacobs MR
    Int J Infect Dis; 2003 Mar; 7 Suppl 1():S13-20. PubMed ID: 12839703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of experimental pneumonia due to penicillin-resistant Streptococcus pneumoniae in immunocompetent rats.
    Gavaldà J; Capdevila JA; Almirante B; Otero J; Ruiz I; Laguarda M; Allende H; Crespo E; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 1997 Apr; 41(4):795-801. PubMed ID: 9087492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamics of the new des-f(6)-quinolone garenoxacin in a murine thigh infection model.
    Andes D; Craig WA
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3935-41. PubMed ID: 14638504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics of penicillin are unaffected by bacterial growth phases of Streptococcus pneumoniae in the mouse peritonitis model.
    Knudsen JD; Frimodt-Møller N; Espersen F
    J Antimicrob Chemother; 1998 Apr; 41(4):451-9. PubMed ID: 9598776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse pneumonia model.
    Darras-Joly C; Bédos JP; Sauve C; Moine P; Vallée E; Carbon C; Azoulay-Dupuis E
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2147-51. PubMed ID: 8878597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMR 3647 human-like treatment of experimental pneumonia due to penicillin-resistant and erythromycin-resistant Streptococcus pneumoniae.
    Piroth L; Desbiolles N; Mateo-Ponce V; Martin L; Lequeu C; Charles PE; Portier H; Chavanet P
    J Antimicrob Chemother; 2001 Jan; 47(1):33-42. PubMed ID: 11152429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypes and genes of resistance of pneumococci to penicillin isolated from children.
    Kotevska V; Trajkovska-Dokic E; Jankoska G; Kaftandzieva A; Panovski N; Petrovska M
    Prilozi; 2009 Jul; 30(1):143-54. PubMed ID: 19736537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Penicillin-resistant pneumococci and the empirical use of penicillins in the treatment of community-acquired acute pneumonia].
    Sánchez C; Armengol R; Mir I; Lite J; Garau J
    Enferm Infecc Microbiol Clin; 1992; 10(6):334-9. PubMed ID: 1391015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a new experimental model of penicillin-resistant Streptococcus pneumoniae pneumonia and amoxicillin treatment by reproducing human pharmacokinetics.
    Piroth L; Martin L; Coulon A; Lequeu C; Duong M; Buisson M; Portier H; Chavanet P
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2484-92. PubMed ID: 10508029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic activity of ertapenem versus penicillin-susceptible and penicillin-non-susceptible Streptococcus pneumoniae using an in vitro model.
    Zhanel GG; Derkatch S; Laing N; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2007 Jan; 59(1):144-7. PubMed ID: 17079238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suboptimal antibiotic dosage as a risk factor for selection of penicillin-resistant Streptococcus pneumoniae: in vitro kinetic model.
    Odenholt I; Gustafsson I; Löwdin E; Cars O
    Antimicrob Agents Chemother; 2003 Feb; 47(2):518-23. PubMed ID: 12543652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.